Browse by People

Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 25.

Wong, SPY, Huda, M, English, P, Bargiota, A, Wilding, JPH ORCID: 0000-0003-2839-8404, Johnson, A, Corrall, R and Pinkney, JH
(2019) Adipokines and the insulin resistance syndrome in familial partial lipodystrophy caused by a mutation in lamin A/C (vol 48, pg 2641, 2005). DIABETOLOGIA, 62 (4). 732 - 732.

Ashrafi, R, Modi, P, Oo, AY, Pullan, DM, Jian, K, Zhang, H, Gerges, J Yanni, Hart, G, Boyett, MR, Davis, GK
et al (show 1 more authors) (2017) Arrhythmogenic gene remodelling in elderly patients with type 2 diabetes with aortic stenosis and normal left ventricular ejection fraction. EXPERIMENTAL PHYSIOLOGY, 102 (11). 1424 - 1434.

Wilding, JPH
(2018) Beyond lifestyle interventions: exploring the potential of anti-obesity medications in the UK. Clinical obesity, 8 (3). 211 - 225.

Wilding, JPH ORCID: 0000-0003-2839-8404, Godec, T, Khunti, K, Pocock, S, Fox, R, Smeeth, L, Blak, B, Clauson, P, Fenici, P, Hammar, N
et al (show 2 more authors) (2017) Changes in HbA(1c) and weight after initiation of second-line therapy in patients with type 2 diabetes in clinical practice. .

Ashrafi, R
(2016) DIABETES AND OBESITY: EVIDENCE FOR A CARDIOMYOPATHY. PhD thesis, University of Liverpool.

Wiviott, SD, Raz, I, Bonaca, MP, Mosenzon, O, Kato, ET, Cahn, A, Silverman, MG, Zelniker, TA, Kuder, JF, Murphy, SA
et al (show 11 more authors) (2019) Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. NEW ENGLAND JOURNAL OF MEDICINE, 380 (4). 347 - 357.

Le Roux, CW, Lau, DCW, Fujioka, K, Greenway, F, Wilding, JPH ORCID: 0000-0003-2839-8404, Jacobsen, PB, Skjoth, T and Madsbad, S
(2017) Early weight loss responders to liraglutide 3.0mg had greater weight loss, regression to normoglycaemia, and reduced Type 2 diabetes development at three years vs early non-responders: SCALE Obesity and Prediabetes. .

Zelniker, TA, Raz, I, Mosenzon, O, Dwyer, JP, Heerspink, HJL, Cahn, A, Im, K, Bhatt, DL, Leiter, LA, McGuire, DK
et al (show 5 more authors) (2019) Effect of dapagliflozin on cardiovascular outcomes in patients with type 2 diabetes according to baseline renal function and albuminuria status: Insights from DECLARE-TIMI 58. .

Steele, T, Narayanan, RP, James, M, James, J, Mazey, N and Wilding, JPH
(2017) Evaluation of Aintree LOSS, a community-based, multidisciplinary weight management service: outcomes and predictors of engagement. Clinical obesity, 7 (6). 368 - 376.

Wilding, JPH ORCID: 0000-0003-2839-8404, Overgaard, RV, Jacobsen, LV, Jensen, CB and le Roux, CW
(2016) Exposure-response analyses of liraglutide 3.0 mg for weight management. Diabetes, Obesity and Metabolism: a journal of pharmacology and therapeutics, 18 (5). 491 - 499.

Narayanan, RP, Weeks, AD ORCID: 0000-0002-1909-337X, Quenby, S ORCID: 0000-0003-3221-5471, Rycroft, D, Hart, A, Longworth, H, Charnley, M, Abayomi, J ORCID: 0000-0002-8133-5595, Topping, J, Turner, MA ORCID: 0000-0002-5299-8656
et al (show 1 more authors) (2016) Fit for Birth - the effect of weight changes in obese pregnant women on maternal and neonatal outcomes: a pilot prospective cohort study. Clinical obesity, 6 (1). 79 - 88.

Wilding, JPH ORCID: 0000-0003-2839-8404, Fujioka, K, Greenway, F, Lau, DCW, O'Neil, P, Jacobsen, PB, Skjoth, TV and Madsbad, S
(2016) Greater weight loss and regression to normoglycaemia, and reduced risk of T2D, at 3 years in early weight loss responders to liraglutide 3.0 mg vs early non-responders. .

Davies, KA Bowden, Sprung, VS ORCID: 0000-0002-2666-4986, Norman, JA, Wilding, JPH ORCID: 0000-0003-2839-8404, Kemp, GJ and Cuthbertson, DJ
(2017) Implementing a step reduction model to examine the metabolic effects of physical inactivity. .

Al-Bazz, DY and Wilding, JPH ORCID: 0000-0003-2839-8404
(2020) Is the latest evidence for cardiovascular protection with glucose-lowering medicines being implemented in clinical practice? .

Aditya, B
(2016) Mechanisms underlying diabetes remission after weight loss surgery for morbid obesity: energy restriction, weight loss, gut hormones or adipokines? Doctor of Medicine thesis, University of Liverpool.

Hydes, TJ, Summers, N, Brown, E, Alam, U ORCID: 0000-0002-3190-1122, Thomaides-Brears, H, Wilding, JPH ORCID: 0000-0003-2839-8404 and Cuthbertson, DJ ORCID: 0000-0002-6128-0822
(2020) Mechanisms, screening modalities and treatment options for individuals with non‐alcoholic fatty liver disease and type 2 diabetes. Diabetic Medicine.

Sprung, VS ORCID: 0000-0002-2666-4986, Davies, KA Bowden, Norman, JA, Thompson, A ORCID: 0000-0002-7087-9415, Wilding, JPH ORCID: 0000-0003-2839-8404, Jones, H, Kemp, GJ and Cuthbertson, DJ
(2018) Metabolically healthy and unhealthy obesity: Metabolic health status rather than obesity is a more accurate prognostic marker for cardiovascular health. .

Bray, GA, Kim, KK, Wilding, JPH ORCID: 0000-0003-2839-8404 and Federation, World Obesity
(2017) Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. OBESITY REVIEWS, 18 (7). 715 - 723.

Wilding, JPH ORCID: 0000-0003-2839-8404 and Bain, SC
(2016) Role of incretin-based therapies and sodium-glucose co-transporter-2 inhibitors as adjuncts to insulin therapy in Type 2 diabetes, with special reference to IDegLira. DIABETIC MEDICINE, 33 (7). 864 - 876.

Davies, MJ, Baldry, EL, Bodicoat, DH, Chatterjee, S, Edwardson, CL, Gray, LJ, Khunti, K, Sargeant, JA, Stensel, DJ, Webb, DR
et al (show 4 more authors) (2020) The SGLT2 inhibitor empagliflozin does not stimulate compensatory appetite responses in patients with excess adiposity and type 2 diabetes. .

Longworth, H, McCallin, K, Narayanan, RP, Turner, MA ORCID: 0000-0002-5299-8656, Quenby, S ORCID: 0000-0003-3221-5471, Rycroft, D, Charnley, M, Abayomi, J ORCID: 0000-0002-8133-5595, Topping, J, Weeks, AD ORCID: 0000-0002-1909-337X
et al (show 1 more authors) (2017) Screening methods for obstructive sleep apnoea in severely obese pregnant women. Clinical obesity, 7 (4). 239 - 244.

Nair, S
(2016) Variability in Creatinine and Estimated Glomerular Filtration Rate in diabetic nephropathy. PhD thesis, University of Liverpool.

Wilding, JPH ORCID: 0000-0003-2839-8404, Rodbard, HW, Uusinarkaus, KT, Van Gaal, L, Hansen, T, Sandberg, AML, Tadayon, S and Davies, MJ
(2019) Weight loss induced by semaglutide once weekly contributes to improved health-related quality of life and treatment satisfaction. .

Zhu, J
(2017) The anti-inflammatory effects of vitamin D receptor agonists on human white preadipocytes. PhD thesis, University of Liverpool.

Wilding, JPH ORCID: 0000-0003-2839-8404, Sharma, AM, Finer, N, Padwal, RS, Skjoth, T, Jensen, CB and Kushner, R
(2017) The efficacy and safety of liraglutide 3.0mg for weight management are similar across baseline Edmonton Obesity Staging System (EOSS) categories: post-hoc analysis at 56 weeks. .

This list was generated on Sat Oct 31 10:43:15 2020 GMT.